(NTS) sheminSay oe 100U); Sen Ye EPI ade (Expanded Programme on immnunization) =4L5 02 upc 7:12 sti A tut Kel Peet he 24 IE 19 7B EP CibSEPI3 Ae -UOA bef EPI e ULFAL Fy ida LEP is Ar Tdu tutus 6b 5S UU 4St-3e¥ 2gbSUE Asie . bp the2-102 2944 By x4 SEE Aer So 6 Byrne UiePEs dr SSE 22002 4x2 sO orSe tee here die GE 22012 He WE Evite btu eprgePe7 Air 22008: 1% YUE EP SEV Lice 8 Ae E2015 Fie rset EPA Sie Uirthes'9 Ae SC 2Et20175,52Rotavirus Vaccine 17 te UL d:104Ur < Mycobacterium Tuberculosis:—!2,8s DrutorSte13 Ae OL AE nin Poe Siig tude ind hy 14 A)ir “ "= U7"(Poliomyelitis) ly 1, te Ge MI (Daphtheriaydc#15 Air (Coryne Bacterium Diphtheriae) 5c! Zt te Me bre a AUBv16 de ~< treo (Brodetella Pertussis): AL AA LU ie UL ininA Arete. tree (Whooping Cogh) x < ened -< EL (Clostridium Tetaniy, eae Lite Ine Lu vtabi thon 19 Lie ~< HE (Hib Becteriay 26 Spit yore. Cate eli bie e222 A Ie -urZ (Koplik Spots Sept lot nth yo23 (8CG-Pheumococcal-Hib-Tetanus)ex5+ (OPV-Routa-IPV-Hep-B-Meastes_oxSinuiiy SU bet lor Beas: (8CG-OPV-Measles) 3. Se dbs uyeehiBcayius.d:28 L- ~(Intradermal) 2 kos ie 24 rheTe UP (Cold Chain) A226 Air Lip SPVC LILLE Ye LE athe etn Sielt ULM SY fatale surdes ALMuetiar Ar &¢ (Delergents)=44(Dettol) (Antiseptic) /e1z—t te He Huger (Pentavelant) obvi 28 ir waitin Sabin en Shee Sf t(Route)2s.s(Dose) ish Soe4(Pentavelant) wot tes:29 A Uir LE aig té Lolafina 0SMLIiSor4 Pentavelant) erste te Uy eAUEPCV-10:30 Air Peo tonBuvinter cw SUZ e(Route)2s.1i(Dose) x3 PCV-10 :31, Air ZL ploipreLonst 30.5 ML se Ips 100% L133 592 Uir AZ, PEE WIE soldier ph LAAs SALE tee HOSA Sn tundil ROE oom os Air Actin MU QSitrmd ze hsg one “si(Dose) isi IPV 36 le 2omme23.gia/3d Ue 24 dee O.5ml IPVine iz Sethe A ii tote et B37 de LewnalhbibiiBertidot adsorbed AG eo Su te hot SoursSe Yourensnb Ab lor':38 Ae LFS Gate AIFS 2etein Sell AEFI:39 Aly (ADVERSE EVENTS FOLLOWING IMMUNITZATION) 12 bec 6LE ted Le mL wHo-40 dir Ue bi HL Nels pb Le iL WHOA ee BZ ete Sto Lb BME iL a1 Le (Hep- By Whit rfc B0.c wh te iL 50%: 12 (Hep-C) 6/5147 < 23 eer FL hu, 160— 80 te de WUeL LE eS whe i IGE -e Oi Gk S62 SAP E WL ee EP ay Lee up hee ias doe CAE SL SHEP SL LPL SI (Stnadrad Disposable Syringe) (Auto Disable Syringe) Sete rtVE-LLé us terhiaa Ly E185 € 22827 5 mi vomre EA brie p17 wlan 48 Ale Tetanus (HIB(DPT) Pneumococcal IPVi—iz See IR 6 Ul Ice Line Refregirator 12 Sey sp0:47 ‘ir Solar Direct Drive 12 Sete M48 Ui Vaccine Vail Moniturs-12 Le EiterarE tnohstrtic sabe ?Se VHA 504 URAL Le tedrgcte SUP 51 die (30 Days Electronic Temprature Recorder) LASus psa Zin (Electronic Freeza Indicator ) Teo Ve (Coldroomy. 252 HUir we OH AIL on SEA eho 8 i Srsndy endings Sure wig treA OUASDDULR53 Air (Thermoastat\e er At fetter S L615 Air LLe aL BIEL nh Pip see tye WMI tL Lbs le Soo S bin UL Seale ey 55 Ale Cha oatel te Sore crate rkitsE one See S56 Air ebattinespnle Ox Ph Le tet shu gU ter Sen ie wl pee Ride (Ninh EU Sete eb LEST Air tp Z Ge Ler C UR Pie try pele =, Barty 58 ie ete Eig the BES phe tg Pn eX b whedrad Sy Sen Eailis9 Ue ALE LN tong h nl PP le te Se VL U60 Ur -GLELZILRISDD AN tule. LP ie Ln Ae WLS Sih i Mer Aly th kn 4B G(LLi Se LIL SUL Kh Ze SAENZ GL £2 A oad oes LaeSe Virnivh AMS 63 iy (Montnaly Demand (Dm)=(Monthaly Target Population X# of Schedule Doses x <1 Wastag Multiplying FactorX Estimated Covrage )- Balance See Pi 64 ie SSS HELL BUSA Somber iM MMR LE Ltr ope Septic at esi viverhy65 Ale ie sb Ossie on Sure a Ae Baer BCG 66 Ur BCG- Measles 1/BCG X100 aCe UW BCG LR ita dd Bede uwOPV 67 Ur OPV1-OPV IIL JOPV 1X100 = Caei)esTLUI¥ OPV ead eed LuPcv-1068 Ue PCV(10)1-PCV(10)3/PCV(10)1X100=( 143), % ¥ PCV-10: le See Oe UW PENTAGD cir Pentat-Penta3/Penta1x100=( 4!) 51138 PENTA. ‘Lear ede Luwee70 4) Measles 1-Measles2/Measles1X100= i LA POTL ier (Inter Personal Communication x-'2 Se VPDS:72 he (Vaccine Preventable Diseases Surveillance):._12 Set AL AEPT3 ie (Acute Flacid Paralysis) 17 COL AFORE i: 74 A ie SI N994L IA ; a - ; Greg Tus Sy cur t.2014:75 de Leta! 06 L ely toe e201 teSeg Pushy Ply Loe £2016. 76 Air es reeebret OL Mtoe cane le See CBV:77 Ale (Community Based Vaccinations).—12 Aner Lih Ater4 FeWIL te Yule DSi 278 ie ‘yt £2007-8.—12 fel, MEAEL AL 6 I-13. 19.22007-00/6, 5 79,4 ie LES Auten te VOL FRED G0 Ay Reach Every Distric sz WAieLuwitd fr KK SREDEL le WA Ged fie LaWHO Unicel 4200242 FRED Sp BFS) s:80 involuntry2. Voluntry1Uz PI2S) it ig Leper Lb £03 be Right lobe Left Robe :_1z See eZ Una tae ahs Une te Pere DoF liz Seb n85 Lie we WE tine 2 Poone uu )y ars Ses (OSV) S.LeL 86 Lhe Distric Superdent Vaccination ee SEE (LHS) En hi87 Le Lady Health Supervisor :u2 SuL0 (CMW): Lu88 Ui Community Mid Wife 17 LL iile pene,Se (MNCH)GH us ér90 Ai Mother Neonatal & Child Health :—1z SEU (ORW)h}_Tst91 Air Out Reach Worker 17 TET wweysy dt92 de Inter Personal Communication'—'s Sel (PHO)S. £1.4:93 Ur Primary Health Care isp SUES (Scydioa Uy Sub Cutaneous 1% Sebel (CPR)7 49:95 Ar Cardiopulmonary Resuscitation. Se NPE (ABC) S--< 1:98, Air Airway Breathing Circulation! fe bee (immunityesuc 997 Ui Natural Immunity Artificial Immunity tpBin Seve Fou SUABAS (Anatomy) 526198 le Fed Pt Moles Ge BEL dnt bt ALE Latins -edeJEF Sete¥Z (Asthma) 99 Lhe LPL SMe tet SAIS 100 ir